Enter your email address
Submit
Write your message
Volume 13, Issue 1 (Iranian Journal of Breast Disease 2020)
ijbd 2020, 13(1): 35-45 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mozafari-Motlagh M R, Nejat H, Tozandehjani H, Samari A. Effectiveness of Mindfulness-Integrated Cognitive-Behavioral Therapy in Breast Cancer Pain Management. ijbd 2020; 13 (1) :35-45
URL: http://ijbd.ir/article-1-758-en.html
URL: http://ijbd.ir/article-1-758-en.html
1- 1Department of Psychology, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran , seyedmd@yahoo.com
2- 2Department of Psychology, Quchan Branch, Islamic Azad University, Quchan, Iran
3- 1Department of Psychology, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran
2- 2Department of Psychology, Quchan Branch, Islamic Azad University, Quchan, Iran
3- 1Department of Psychology, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran
Abstract: (4512 Views)
Introduction: Given the high comorbidity of mental conditions and chronic pain in cancer, there is a need for development and administration of interventions for this population. This study aimed to investigate the effectiveness of mindfulness-integrated cognitive-behavioral therapy (MiCBT) in breast cancer pain management.
Methods: In this clinical trial, 24 patients with breast cancer from Omid Hospital in Mashhad were selected via a purposive sampling method and randomly assigned to two groups of intervention (N = 12) and control (N = 12). The participants were assessed using the Short Cancer Pain Scale, Pain Self-Efficacy Questionnaire, and Pain Catastrophizing Scale before, immediately after, and one month after the intervention. The participants in the intervention group received MiCBT for 8 weeks. The control group did not receive any intervention from the research team during the research period. Descriptive statistics (percentage, frequency, mean and standard deviation), chi-square tests, t-tests, and multivariate analysis of covariance were used for data analysis.
Results: After controlling for the pretest scores, there were significant differences between control and intervention groups in perceived pain, pain catastrophizing, and pain self-efficacy immediately and one month after the intervention (P > 0.001). The perceived pain, pain catastrophizing decreased and pain self-efficacy increased immediately and one month after the intervention (P > 0.001). Eta square showed 0.85,0.78 and 0.70 change in perceived pain, pain catastrophizing, and pain self-efficacy immediately and one month. In the follow-up phase, Eta squre were 0.87,0.75 and 0.79 for perceived pain, pain catastrophizing, and pain self-efficacy respectively.
Conclusion: MiCBT is effective in improving pain, pain self-efficacy, and pain catastrophe in patients with breast cancer. Therefore, considering the cost-effectiveness and availability, this program is recommended as a complementary treatment for breast cancer patients.
Methods: In this clinical trial, 24 patients with breast cancer from Omid Hospital in Mashhad were selected via a purposive sampling method and randomly assigned to two groups of intervention (N = 12) and control (N = 12). The participants were assessed using the Short Cancer Pain Scale, Pain Self-Efficacy Questionnaire, and Pain Catastrophizing Scale before, immediately after, and one month after the intervention. The participants in the intervention group received MiCBT for 8 weeks. The control group did not receive any intervention from the research team during the research period. Descriptive statistics (percentage, frequency, mean and standard deviation), chi-square tests, t-tests, and multivariate analysis of covariance were used for data analysis.
Results: After controlling for the pretest scores, there were significant differences between control and intervention groups in perceived pain, pain catastrophizing, and pain self-efficacy immediately and one month after the intervention (P > 0.001). The perceived pain, pain catastrophizing decreased and pain self-efficacy increased immediately and one month after the intervention (P > 0.001). Eta square showed 0.85,0.78 and 0.70 change in perceived pain, pain catastrophizing, and pain self-efficacy immediately and one month. In the follow-up phase, Eta squre were 0.87,0.75 and 0.79 for perceived pain, pain catastrophizing, and pain self-efficacy respectively.
Conclusion: MiCBT is effective in improving pain, pain self-efficacy, and pain catastrophe in patients with breast cancer. Therefore, considering the cost-effectiveness and availability, this program is recommended as a complementary treatment for breast cancer patients.
Keywords: Mindfulness, Cognitive-Behavioral Therapy, Perceived Pain, Pain Catastrophizing, Breast Cancer
Type of Study: Research |
Received: 2019/09/26 | Accepted: 2019/12/23 | Published: 2020/05/21
Received: 2019/09/26 | Accepted: 2019/12/23 | Published: 2020/05/21
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
